Keefe, Bruyette & Woods Lowers Stellus Capital Investment (NYSE:SCM) Price Target to $9.00

Stellus Capital Investment (NYSE:SCM) had its price target cut by Keefe, Bruyette & Woods from $13.00 to $9.00 in a report issued on Monday,Benzinga reports. The brokerage presently has a “market perform” rating on the investment management company’s stock. Keefe, Bruyette & Woods’ target price points to a potential upside of 2.75% from the company’s current price.

Separately, Weiss Ratings restated a “hold (c)” rating on shares of Stellus Capital Investment in a research note on Monday, December 29th. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Stellus Capital Investment presently has a consensus rating of “Hold” and an average target price of $9.00.

Stellus Capital Investment Price Performance

Stellus Capital Investment stock opened at $8.76 on Monday. Stellus Capital Investment has a 52 week low of $8.55 and a 52 week high of $15.39. The company’s 50 day moving average price is $11.64 and its two-hundred day moving average price is $12.37. The stock has a market cap of $253.57 million, a P/E ratio of 9.32 and a beta of 0.68. The company has a quick ratio of 0.14, a current ratio of 0.14 and a debt-to-equity ratio of 1.13.

Stellus Capital Investment (NYSE:SCM) last released its earnings results on Wednesday, March 11th. The investment management company reported $0.29 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.31 by ($0.02). The business had revenue of $23.98 million during the quarter, compared to the consensus estimate of $26.33 million. Stellus Capital Investment had a net margin of 26.48% and a return on equity of 10.28%. On average, equities analysts predict that Stellus Capital Investment will post 1.74 earnings per share for the current year.

Institutional Investors Weigh In On Stellus Capital Investment

Several large investors have recently added to or reduced their stakes in the business. Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Stellus Capital Investment by 65.9% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 156,050 shares of the investment management company’s stock worth $2,038,000 after purchasing an additional 62,002 shares in the last quarter. Inspire Advisors LLC raised its stake in Stellus Capital Investment by 155.5% in the second quarter. Inspire Advisors LLC now owns 62,530 shares of the investment management company’s stock valued at $872,000 after purchasing an additional 38,059 shares in the last quarter. Corient Private Wealth LLC lifted its position in Stellus Capital Investment by 19.4% during the second quarter. Corient Private Wealth LLC now owns 253,763 shares of the investment management company’s stock valued at $3,537,000 after purchasing an additional 41,305 shares during the last quarter. Muzinich & Co. Inc. lifted its position in Stellus Capital Investment by 43.7% during the third quarter. Muzinich & Co. Inc. now owns 206,893 shares of the investment management company’s stock valued at $2,702,000 after purchasing an additional 62,888 shares during the last quarter. Finally, Laurel Wealth Advisors LLC purchased a new position in Stellus Capital Investment in the 2nd quarter worth approximately $405,000. Institutional investors own 13.22% of the company’s stock.

Stellus Capital Investment Company Profile

Stellus Capital Investment Corporation (NYSE: SCM) is a closed-end, externally managed business development company that provides debt and equity financing to middle market companies in the United States. As an investment vehicle specializing in private credit, Stellus focuses on originating and structuring senior secured loans, unitranche facilities, mezzanine debt, and equity co-investments tailored to the unique needs of growing businesses. Its flexible capital solutions are designed to support acquisitions, recapitalizations, growth initiatives, and balance sheet refinancings.

Operating under an evergreen structure, Stellus Capital Investment partners with a diverse group of portfolio companies across industries such as manufacturing, healthcare, business services, and specialty finance.